Sepsis Diagnosis Is Critical in the Age of Antibiotic Resistance
Sepsis is a life-threatening emergency caused by the body's extreme response to infection, requiring rapid diagnosis and treatment.
Category: Sepsis
Sepsis
Latest
Sepsis
Latest
Ad Astra Gets Federal Contract to Advance CBC Diagnostics for Sepsis Detection
The $5 million contract will help develop a diagnostic system that delivers fast CBC results and improves early detection for sepsis.
Sepsis
Latest
Nasal Microbiota is a Potential Sepsis Diagnostic Biomarker
A new study reveals that the nasal microbiota of ICU patients is more effective than gut microbiota in distinguishing sepsis from non-sepsis.
New Research Supports Diagnosis of Sepsis in Children
Researchers harnessed artificial intelligence to analyze data from over 3.5 million children suffering from sepsis.
Read More
Bluejay Diagnostics Evaluates Test for Sepsis Patient Care
The Symphony System is designed to address the need for simple, reliable, rapid, near-patient sepsis testing.
Read More
New Study Highlights Need for Improved Sepsis Diagnosis and Triage
Cytovale detailed the publication of a new peer-reviewed study that highlights the need for rapid sepsis testing.
Read More
Inflammatix Acute Infection and Sepsis Test System Gets FDA Breakthrough Device Designation
Inflammatix says that the U.S. FDA has granted Breakthrough Device Designation for its TriVerity Acute Infection and Sepsis Test System.Â
Read More
Siemens Healthineers Contracts with NIH in Fight Against Sepsis
Siemens Healthineers has contracted with the National Institutes of Health (NIH) to improve antibiotic treatment for sepsis patients.
Read More
Inflammatix Completes Technical Development of Acute Infection and Sepsis Test System
The test system is intended to be used in emergency department settings in patients with suspected acute infection and sepsis.
Read More
Sepsis Diagnosis Gets Point-of-Care Solution
Steripath delivers critical time savings for sepsis diagnosis, improving patient outcomes and providing cost efficiencies.
Read More
New Sepsis Test Could Save Lives in Emergency Departments
Research from the Penn State College of Health and Human Development found that a new blood test for sepsis could save lives and money.
Read More
T2Biothreat Panel Receives FDA 510(k) Clearance
T2 Biosystems, Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the T2Biothreat Panel.
Read More
T2 Biosystems Praises CDC’s Actions to Optimize Hospital Sepsis Programs
T2 Biosystems praised actions taken by the CDC aimed at optimizing hospital sepsis programs in the United States.
Read More
CDC Director Releases New Guidelines to Reduce Sepsis DeathsÂ
CDC Director Mandy Cohen, MD, MPH, is set to release guidelines that offer a roadmap for hospitals to reduce deaths from sepsis.
Read More
Our Lady of the Lake Health Implements Sepsis Diagnostic Tool
A diagnostic tool that detects sepsis in patients in under 10 minutes is now in use at Our Lady of the Lake Regional Medical Center.
Read More
Cytovale Unveils Commercial Launch of Sepsis Test for Emergency Departments
Cytovale announced the U.S. commercial launch of the IntelliSep sepsis test following FDA 510(k) clearance in December 2022.Â
Read More
Why Better Sepsis Diagnosis Results in Better Outcomes
Delay in sepsis diagnosis increases the risk of dying by 8% every hour; and can lead to the unnecessary use of strong antibiotic therapies.
Read More
C. auris Diagnostic Submitted for FDA Breakthrough Device Designation
T2 Biosystems Inc. has submitted an application with the FDA for Breakthrough Device Designation for the company’s Candida auris test.
Read More